MYD88 mutations are commonly identified recurring mutations in chronic lymphocytic leukemia (CLL), B-cell lymphoma, and Waldenstrom’s macroglobulinemia [23–25]. This evidence concerns the gene MYD88 and B-cell chronic lymphocytic leukemia.